WHO recommends triple drug therapy to accelerate global elimination of lymphatic filariasis

The World Health Organization (WHO) is recommending an alternative three drug treatment to accelerate the global elimination of lymphatic filariasis—a disabling and disfiguring neglected tropical disease.

The treatment, known as IDA, involves a combination of ivermectin, diethylcarbamazine citrate and albendazole. It is being recommended annually in settings where its use is expected to have the greatest impact. WHO, November 3, 2017.

 

Share This Post:

Facebook
Twitter
LinkedIn
Email
Print